- Immuron to host Live Virtual Event
- Immuron Travelan® sales continued strong growth
- Immuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the US
- Immuron Presentation Australian Biologics Festival 2024
- Immuron achieves record Travelan® sales
- Immuron CEO, Steven Lydeamore Investor Webinar Presentation
- Immuron achieves record half yearly Travelan® sales
- Immuron Clinical Trials Update
- Immuron Announces First Patients Enrolled in Campylobacter Challenge Clinical Study
- Immuron CEO Steven Lydeamore Investor Webinar Presentation
More ▼
Key statistics
On Friday, Immuron Ltd (IMC:ASX) closed at 0.105, 61.54% above the 52 week low of 0.065 set on Mar 04, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.105 |
---|---|
High | 0.105 |
Low | 0.105 |
Bid | 0.10 |
Offer | 0.105 |
Previous close | 0.105 |
Average volume | 387.32k |
---|---|
Shares outstanding | 228.00m |
Free float | 187.04m |
P/E (TTM) | -- |
Market cap | 23.94m AUD |
EPS (TTM) | -0.017 AUD |
Data delayed at least 20 minutes, as of Apr 26 2024 07:10 BST.
More ▼